Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 348

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Basiorka, Ashley A., McGraw, Kathy L., Eksioglu, Erika A., Chen, Xianghong, Johnson, Joseph, Zhang, Ling, Zhang, Qing, Irvine, Brittany A., Cluzeau, Thomas, Sallman, David A., Padron, Eric, Komrokji, Rami, Sokol, Lubomir, Coll, Rebecca C., Robertson, Avril A. B., Cooper, Matthew A., Cleveland, John L., O’Neill, Luke A., Wei, Sheng, List, Alan F.·2016·Blood
DOI 10.1182/blood-2016-07-730556
Open this paper in CoChat — free account

Abstract

Key Points: Key biological features of MDSs are explained by NLRP3 inflammasome activation, which drives pyroptotic cell death and β-catenin activation. Alarmin signals and founder gene mutations license this redox-sensitive inflammasome platform.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2016-07-730556

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 50

  1. Span, 2007, Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions, Leuk Res, 31, 1659, 10.1016/j.leukres.2007.06.013 · DOI
  2. Garcia-Manero, 2014, Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management, Am J Hematol, 89, 97, 10.1002/ajh.23642 · DOI
  3. Bejar, 2011, Unraveling the molecular pathophysiology of myelodysplastic syndromes, J Clin Oncol, 29, 504, 10.1200/JCO.2010.31.1175 · DOI
  4. Raza, 1995, Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes, Blood, 86, 268, 10.1182/blood.V86.1.268.bloodjournal861268 · DOI
  5. Parker, 2000, The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS, Blood, 96, 3932, 10.1182/blood.V96.12.3932 · DOI
  6. Tehranchi, 2003, Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors, Blood, 101, 1080, 10.1182/blood-2002-06-1774 · DOI
  7. Takizawa, 2012, Demand-adapted regulation of early hematopoiesis in infection and inflammation, Blood, 119, 2991, 10.1182/blood-2011-12-380113 · DOI
  8. Mundle, 1996, Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes, Blood, 88, 2640, 10.1182/blood.V88.7.2640.bloodjournal8872640 · DOI
  9. Ehrchen, 2009, The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer, J Leukoc Biol, 86, 557, 10.1189/jlb.1008647 · DOI
  10. Maratheftis, 2007, Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes, Clin Cancer Res, 13, 1154, 10.1158/1078-0432.CCR-06-2108 · DOI
  11. Rhyasen, 2013, Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome, Cancer Cell, 24, 90, 10.1016/j.ccr.2013.05.006 · DOI · Paper page
  12. Hofmann, 2002, Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow, Blood, 100, 3553, 10.1182/blood.V100.10.3553 · DOI
  13. Bergsbaken, 2009, Pyroptosis: host cell death and inflammation, Nat Rev Microbiol, 7, 99, 10.1038/nrmicro2070 · DOI
  14. Brennan, 2000, Salmonella induces macrophage death by caspase-1-dependent necrosis, Mol Microbiol, 38, 31, 10.1046/j.1365-2958.2000.02103.x · DOI
  15. Kessel, 2013, Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers, Clin Immunol, 147, 229, 10.1016/j.clim.2012.11.008 · DOI
  16. Cookson, 2001, Pro-inflammatory programmed cell death, Trends Microbiol, 9, 113, 10.1016/S0966-842X(00)01936-3 · DOI
  17. Fantuzzi, 1999, Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1), J Clin Immunol, 19, 1, 10.1023/A:1020506300324 · DOI
  18. Lim, 2009, Oxidative modifications of S100 proteins: functional regulation by redox, J Leukoc Biol, 86, 577, 10.1189/jlb.1008608 · DOI
  19. Simard, 2013, S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB(1.), PLoS One, 8, e72138, 10.1371/journal.pone.0072138 · DOI
  20. Sester, 2015, A novel flow cytometric method to assess inflammasome formation, J Immunol, 194, 455, 10.4049/jimmunol.1401110 · DOI
  21. Franklin, 2014, The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation, Nat Immunol, 15, 727, 10.1038/ni.2913 · DOI · Paper page
  22. Velegraki, 2013, Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production, Haematologica, 98, 1206, 10.3324/haematol.2012.064642 · DOI
  23. Chirico, 2014, High-mobility group box 1 (HMGB1) in childhood: from bench to bedside, Eur J Pediatr, 173, 1123, 10.1007/s00431-014-2327-1 · DOI
  24. Fink, 2006, Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages, Cell Microbiol, 8, 1812, 10.1111/j.1462-5822.2006.00751.x · DOI
  25. Ali, 1999, Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes, J Hematother Stem Cell Res, 8, 343, 10.1089/152581699320108 · DOI
  26. Rharass, 2014, Ca2+-mediated mitochondrial reactive oxygen species metabolism augments Wnt/β-catenin pathway activation to facilitate cell differentiation, J Biol Chem, 289, 27937, 10.1074/jbc.M114.573519 · DOI
  27. Kajla, 2012, A crucial role for Nox 1 in redox-dependent regulation of Wnt-β-catenin signaling, FASEB J, 26, 2049, 10.1096/fj.11-196360 · DOI
  28. Xu, 2008, Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome, Br J Haematol, 140, 394, 10.1111/j.1365-2141.2007.06914.x · DOI
  29. Masala, 2012, Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells, Leuk Res, 36, 1290, 10.1016/j.leukres.2012.05.023 · DOI
  30. Bello, CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q) [published online ahead of print 8 June 2015], Br J Haematol
  31. Obeng, 2014, Mutant splicing factor 3b subunit 1 (SF3B1) causes dysregulated erythropoiesis and a stem cell disadvantage, Blood, 124, 828, 10.1182/blood.V124.21.828.828 · DOI
  32. Abdel-Wahab, 2013, Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo, J Exp Med, 210, 2641, 10.1084/jem.20131141 · DOI
  33. Graubert, 2011, Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes, Nat Genet, 44, 53, 10.1038/ng.1031 · DOI
  34. Pellagatti, 2010, Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells, Leukemia, 24, 756, 10.1038/leu.2010.31 · DOI
  35. Liao, 2013, Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion, Inflamm Res, 62, 89, 10.1007/s00011-012-0555-2 · DOI
  36. Heid, 2013, Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation, J Immunol, 191, 5230, 10.4049/jimmunol.1301490 · DOI
  37. Bauernfeind, 2011, Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome, J Immunol, 187, 613, 10.4049/jimmunol.1100613 · DOI · Paper page
  38. Doussiere, 2002, The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils, Eur J Biochem, 269, 3246, 10.1046/j.1432-1033.2002.03002.x · DOI
  39. Kerkhoff, 2005, The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2, FASEB J, 19, 467, 10.1096/fj.04-2377fje · DOI
  40. Coant, 2010, NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon, Mol Cell Biol, 30, 2636, 10.1128/MCB.01194-09 · DOI
  41. Wu, 2008, Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling, Cell, 133, 340, 10.1016/j.cell.2008.01.052 · DOI
  42. Schneider, 2016, Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9, Nat Med, 22, 288, 10.1038/nm.4047 · DOI
  43. Lee, 2016, Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins, Nat Med, 22, 672, 10.1038/nm.4097 · DOI
  44. Yang, 2016, Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm, Blood, 127, 3410, 10.1182/blood-2015-11-679431 · DOI
  45. Kashio, 2012, Redox signal-mediated sensitization of transient receptor potential melastatin 2 (TRPM2) to temperature affects macrophage functions, Proc Natl Acad Sci USA, 109, 6745, 10.1073/pnas.1114193109 · DOI
  46. Zhong, 2013, TRPM2 links oxidative stress to NLRP3 inflammasome activation, Nat Commun, 4, 1611, 10.1038/ncomms2608 · DOI
  47. Yamamoto, 2008, TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration, Nat Med, 14, 738, 10.1038/nm1758 · DOI
  48. Kühn, 2005, TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose, Pflugers Arch, 451, 212, 10.1007/s00424-005-1446-y · DOI
  49. Rassool, 2007, Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?, Cancer Res, 67, 8762, 10.1158/0008-5472.CAN-06-4807 · DOI
  50. Funato, 2006, The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled, Nat Cell Biol, 8, 501, 10.1038/ncb1405 · DOI

Cited by

Metadata

Authors
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., Padron, E., Komrokji, R., Sokol, L., Coll, R. C., Robertson, A. A. B., Cooper, M. A., Cleveland, J. L., O’Neill, L. A., Wei, S., & List, A. F.
Affiliations
  • Cancer Biology Ph.D. Program, Department of Malignant Hematology,
  • Department of Malignant Hematology,
  • Department of Immunology,
  • Analytic Microscopy Core Facility, and
  • Department of Hematopathology, H. Lee Moffitt Cancer Center, Tampa, FL;
  • Department of Hematology, Centre Hospitalier Universitaire de Nice, Nice, France;
  • Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia;
  • Department of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, FL; and
  • Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland
Venue
Blood
Publisher
American Society of Hematology
Published
2016-12-22
Volume
128
Issue
25
Pages
2960-2975
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood-2016-07-730556
Cited by
348
References
12
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review